United Kingdom

Case Law, United Kingdom

(Bristows)/

The High Court has granted the Claimants’ request for declarations of non-infringement (“DNIs”) regarding several national designations of the Defendant’s European Patent for a pemetrexed disodium and vitamin B12 combination in respect of reconstitution of the Claimants’ lyophilised pemetrexed product when reconstituted in dextrose solution. The issues in this case were remitted by the Court…

Brexit, European Union, NPE, Unitary Patent, United Kingdom, UPC

/

Although patent litigation in Europe is fragmented, businesses have been able to cope and a unitary system may not be strictly necessary for the patent system to function in Europe. However, the new UPC does represent an opportunity to improve the system via greater efficiency and consistency.  Dr Luke McDonagh of the Law School at…

United Kingdom

, (EIP)/

While the subject of the appropriate court fees to pay when issuing proceedings is not normally an exciting one to write about (indeed some readers of this post will say that this remains the case) a recent application concerning the appropriate fees to pay in a trade mark action (Lifestyles Equities CV v Sportsdirect.com Retail…

Brexit, European Union, Unitary Patent, United Kingdom, UPC

/

The UK’s Intellectual Property Office has published a statement on the future of IP law after the Brexit vote of 23 June 2016, saying there will be ‘no immediate changes’ regarding the Unitary Patent system. In its document ‘IP and BREXIT: The facts‘, the UK IPO writes: ‘there has been much speculation on the future of many intellectual…

(Cross-border) jurisdiction, Germany, Procedure, United Kingdom

(Bristows)/

by Gregory Bacon The English courts are not averse to determining disputes concerning foreign rights, including intellectual property rights. Readers will no doubt be aware of the recent case between Actavis and Eli Lilly in which Actavis sought declarations of non-infringement in relation to the UK and foreign designations of Eli Lilly’s European patent concerning…

Antibodies, Exceptions to patentability, Industrial application, NPE, Pharma, Sufficiency of disclosure, United Kingdom, Validity

(Bristows)/

by Rachel Mumby Those readers who are unfamiliar with the excessively optimistic outlook of Mr Wilkins Micawber in Charles Dicken’s novel David Copperfield, would be forgiven for having had to look up the word “Micawberism” on reading it in the judgment of Floyd J (as he then was) in Blacklight Power Inc. v The Comptroller-General…

Brexit, European Union, Unitary Patent, United Kingdom, UPC

/

Analysing whether, if the UK ratifies the UPC, further participation in the Unitary Patent system might be possible and on what legal basis. That is the main objective of a group of patent professionals in the UK, which has been convened by Simmons partner Kevin Mooney after the Brexit vote of 23 June 2016. Mooney is…

Brexit, European Union, Unitary Patent, United Kingdom, UPC

/ /3 Comments

One month after the UK referendum, discussion has deepened and several papers have been published about the Brexit vote and the Unitary Patent system. Is it possible to both save the system and keep the UK in? EPO president Benoît Battistelli thinks the best case scenario would be for the UK to ‘go ahead as…